基因评分量化急性失代偿期肝硬化患者的全身性炎症
研究纳入700例急性失代偿期肝硬化(ADC)患者,入院时检测标准生物标志物和全基因组RNA表达,构建基于28个免疫细胞相关基因的CLIF-SIG评分。CLIF-SIG评分反映临床严重度的准确性优于CLIF-SBC评分(AUC 0.803 vs 0.658),0.386为最佳截断值,入院时评分>0.386者80%在住院期间发生慢加急性肝衰竭(ACLF)。
要点
- CLIF-SIG评分反映ADC患者全身性炎症所致临床严重度的准确性优于CLIF-SBC评分。
- CLIF-SIG评分0.386为区分不良结局的最佳截断值,见于所有临床场景。
- 入院时CLIF-SIG评分>0.386的患者中80%在住院期间发生ACLF。
核心结论
- 在ADC患者中,CLIF-SIG评分是全身性炎症、临床病程严重度和预后的准确评估工具。
研究设计与样本
- 研究纳入700例急性失代偿期肝硬化患者,于入院时采集血液检测标准生物标志物(白细胞计数、C反应蛋白、细胞因子)并行全基因组RNA测序。
- 构建基于标准生物标志物的CLIF-SBC评分和由高严重度与低严重度临床表型比较中28个差异表达最显著的免疫细胞相关基因组成的CLIF-SIG评分。
- 700例患者中375例在随访期间重复检测CLIF-SIG评分一次,46例重复检测3次或以上。
主要发现
- CLIF-SIG评分反映全身性炎症所致临床严重度的准确性优于CLIF-SBC评分,曲线下面积0.803 vs 0.658。
- CLIF-SIG评分0.386(约登指数)为区分不良结局患者与其他患者的最佳截断值,见于所有临床场景。
- 连续检测CLIF-SIG评分显示78%的患者入院时处于全身性炎症波峰的峰值或下降段。
- 入院时CLIF-SIG评分>0.386的患者中80%在住院期间发生ACLF。
关键数值与推荐
- CLIF-SIG评分曲线下面积0.803 vs CLIF-SBC评分0.658。
- CLIF-SIG评分0.386(约登指数)为区分不良结局的最佳截断值。
- 入院时CLIF-SIG评分>0.386的患者中80%在住院期间发生ACLF。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Quantifying systemic inflammation (SI) in acutely decompensated cirrhosis (ADC) is of major importance because SI is a driver of the most severe forms of ADC, including acute-on-chronic liver failure (ACLF). Blood biomarkers of SI already evaluated in ADC failed to appropriately assess SI in ADC. We aimed to investigate whether gene expression related to circulating immune cells could quantify SI in ADC. METHODS: Standard biomarkers (white cell count, C reactive protein, cytokines) and genome-wide RNA expression (RNA-sequencing) were obtained in blood from 700 patients with ADC at the time of their hospital admission. A composite score based on standard biomarkers of SI (Chronic Liver Failure-Standard Biomarkers Composite (CLIF-SBC) score) and a gene score (CLIF-Systemic Inflammation Gene (SIG) score) composed of the 28 top differentially expressed immune cell-related genes in the comparison between high-severity and low-severity clinical phenotypes were computed. Among the 700 patients, the CLIF-SIG score was repeated once during follow-up in 375 patients, and 3 times or more in 46 patients. RESULTS: The CLIF-SIG score was more accurate in reflecting clinical severity induced by SI than the CLIF-SBC score (area under the curve 0.803 vs 0.658). A CLIF-SIG score of 0.386 (Youden Index) was the best cut-off level discriminating patients with poor outcomes from the others, in all clinical scenarios. Sequential measurement of the CLIF-SIG score showed that 78% of patients were admitted at the peak or descending part of the SI-wave. ACLF developed during hospitalisation in 80% of patients with a CLIF-SIG score >0.386 on admission. CONCLUSIONS: In patients with ADC, the CLIF-SIG score is an accurate estimator of SI, clinical course severity and prognosis.
引用
- Trebicka J, Aguilar F, Queiroz Farias A, et al. Gene score to quantify systemic inflammation in patients with acutely decompensated cirrhosis. Gut. 2025. PMID: 40011033. doi:10.1136/gutjnl-2024-333876
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。